European Journal of Cancer
Volume 43, Issue 15 , Pages 2253-2263 , October 2007

The role of surgery in the management of older women with breast cancer

Received 24 April 2007 ,Revised 12 July 2007 ,Accepted 18 July 2007.

References 

  1. Brayne C, Matthews FE, McGee MA, Jagger C. Health and ill-health in the older population in England and Wales. The MRC Cognitive Function and Ageing Study, (MRC-CFAS). Age Ageing. 2001;30:53–62
  2. Wyld L, Garg DK, Brown H, Reed MWR. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer. 2004;90(8):1486–1491
  3. Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 years. Br J Cancer. 2007;96:1197–1203
  4. Diab SG, Elledge RM, Clarke GM. Tumour characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;92:550–556
  5. Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, et al. Patterns of breast carcinoma treatment in older women. Cancer. 2000;89:561–573
  6. Eaker S, Dickman PW, Bergkvist L, Holmberg L. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PloS Med. 2006;3(3):e25
  7. Wyld L, Reed MW. The need for targeted research into breast cancer in the elderly. BJS. 2003;90:388–399
  8. Guadagnoli E, Shapiro C, Gurwitz JH, et al. Age-related patterns of care: evidence against ageism in the treatment of early stage breast cancer. J Clin Oncol. 1997;15:2338–2344
  9. Daidone MG, Coradini D, Martelli G, Veneroni S. Primary breast cancer in elderly women: biological profile and relation to clinical outcome. Crit Rev Oncol/Haematol. 2003;45:313–325
  10. Herbsman H, Feldman J, Seldera J, Gardner B, Alfonso AE. Survival following breast cancer surgery in the elderly. Cancer. 1981;47:2358–2363
  11. Gann PH, Colilla SA, Gapster SM, Winchester DJ, Winchester DP. Factors associated with axillary lymph node metastases from breast cancer. Cancer. 1999;86:1511–1519
  12. Chadha M, Habon AB, Friedman P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer. 1994;73:350–353
  13. Caywood J, Gray RJ, Hentz J, Pockaj BA. Older age independently predicts a lower risk of sentinel node metastasis in breast cancer. Ann Surg Oncol. 2005;12(12):1061–1065
  14. Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinski RA, Bernstein JL. The consequences of undertreating breast cancer in the elderly. J Am Coll Surgeons. 2001;192:698–707
  15. Schaefer G, Rosen PP, Lesser ML, Kinne DW, Beatie EJ. Breast carcinoma in elderly women: pathology, prognosis and survival. Pathol Ann. 1984;19:195–218
  16. Wenger CR, Beardslee S, Owens MA, et al. DNA ploidy, S-phase and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat. 1993;28:9–20
  17. McCarty KS, Silva JS, Cox EB, Leight GS, Wells SA, McCarty KS Snr. Relationship of age and menopausal status to oestrogen receptor content in primary carcinoma of the breast. Ann Surg. 1983;197:123–127
  18. Berg JW, Hutter RVP. Breast cancer. Cancer. 1995;75:257–269
  19. Siegelmann-Danielli N, Khandelwal V, Wood GC. Breast cancer in elderly women: combined effect of tumour feature, age, co-morbidities and treatment approach. In: Poster at the San Antonio breast cancer conference; 2004.
  20. Satariano WA, Ragland DR. The effect of co-morbidity on 3-year survival of women with primary breast cancer. Ann Int Med. 1994;120:104–110
  21. Riste L, Khan F, Cruickshank K. High prevalence of type II diabetes in all ethnic groups, including Europeans, in a British Inner City. Diabetes Care. 2001;24:1377–1383
  22. Zaher C, Goldberg GA, Kadlubek P. Estimating angina prevalence in a managed care population. Am J Manage Care. 2004;10:S339–S346
  23. MacDonald BK, Cockerell OC, Sanders WAS, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community based study in the UK. Brain. 2000;123:665–676
  24. De Bacquer D, De Backer G, Kornitzer M. Prevalences of ECG findings in large population based samples of men and women. Heart. 2000;84:625–633
  25. Lindberg A, Eriksson B, Larsson L-G, Ronmark E, Sandstrom T, Lundback B. Seven year cumulative incidence of COPD in an age stratified general population sample. Chest. 2006;129:879–885
  26. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383
  27. Flemming ST, Rastogi A, Dmitrienko A, Johnson K. A comprehensive prognostic index to predict survival based on multiple co-morbidities: a focus on breast cancer. Med Care. 1999;37(6):601–614
  28. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern cooperative oncology group performance status in elderly cancer patients: an Italian group for geriatric oncology study. J Clin Oncol. 2002;20:494–502
  29. Audisio RA, Ramesh H, Longo WE, Zbar AP, Pope D. Pre-operative assessment of surgical risk in oncogeriatric patients. Oncologist. 2005;10:262–268
  30. Inouye SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalised patients. J Am Med Assoc. 1998;279(15):1187–1193
  31. Audisio RA, Osman N, Audisio MM, Montalto F. How do we manage breast cancer in the elderly patients? A survey among members of the British Association of Surgical Oncologists, (BASO). Crit Rev Oncol/Haematol. 2004;52:135–141
  32. Petrisek AC, Laliberte LL, Allen SM, Mor V. The treatment decision-making process: age differences in a sample of women recently diagnosed with non-recurrent, early stage breast cancer. Gerontologist. 1997;37:598–608
  33. Ganz PA, Lee JJ, Sim M-S, Polinsky ML, Schag AC. Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer. J Clin Epidemiol. 1992;45:473–485
  34. Sandison AJP, Gold DM, Wright P, Jones PA. Breast conservation or mastectomy: treatment choice of women age 70 years and older. Br J Surg. 1996;83:994–996
  35. Kesseler HJ, Seton JZ. The treatment of operable breast cancer in the elderly female. Am J Surg. 1978;135:664–666
  36. Hunt KE, Fry DE, Bland KI. Breast carcinoma in the elderly patient: an assessment of operative risk, morbidity and mortality. Am J Surg. 1980;140:339–342
  37. Lynch EP, Welch KJ, Carabuena JM, Eberlein TJ. Thoracic epidural anaesthesia improves outcome after breast surgery. Ann Surg. 1995;222(5):663–669
  38. Groeben H, Schafer B, Pavlakovic G, Silvanus M-T, Peters J. Lung function under high thoracic segmental epidural anaesthesia with ropivacaine or bupivacaine in patients with severe obstructive pulmonary disease undergoing breast surgery. Anaesthesiology. 2002;96:536–541
  39. Greengrass R, O’Brien F, Lyerly K, et al. Paravertebral block for breast cancer surgery. Can J Anaesthesia. 1996;43(8):858–861
  40. Atanassoff PG, Alon E, Weiss BM. Intercostal nerve block for lumpectomy: superior postoperative pain relief with bupivacaine. J Clin Anaesthesia. 1994;6(1):47–51
  41. Oakley N, Dennison AR, Shorthouse AJ. A prospective audit of simple mastectomy under local anaesthesia. Eur J Surg Oncol. 1996;22:134–136
  42. Brenin DR, Morrow M, Moughan J, Owen JB, Wilson JF, Winchester DP. Management of axillary lymph nodes in breast cancer: a national patterns of care study of 17,151 patients. Ann Surg. 1999;230(5):686–691
  43. Yancik R, Ries LG, Yates JW. Breast cancer in ageing women. A population based study of contrasts in stage, surgery and survival. Cancer. 1989;63:976–981
  44. Truong PT, Bernstein V, Wai E, Chua B, Speers C, Olivotto IA. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;54(3):794–8003
  45. DiFronzo LA, Hansen NM, Stern SL, Brennan MB, Guiliano AE. Does sentinel lymphadenectomy improve staging and alter therapy in elderly women with breast cancer?. Ann Surg Oncol. 2000;7:406–410
  46. Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006;24(3):337–344
  47. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomised clinical trial comparing radical mastectomy and total mastectomy with or without radiation. New Engl J Med. 1985;312:674–681
  48. Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: a randomised trial to assess the role of axillary radiotherapy. Ann Oncol. 2005;16:383–388
  49. Chua B, Ung O, Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J. 2002;8:15–22
  50. Fredriksson I, Liljegren G, Arnesson L-G, et al. Consequences of axillary recurrence after conservative breast surgery. Br J Surg. 2002;89:902–908
  51. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1991;9:988–996
  52. Lythgoe JP, Palmer MK. Manchester regional breast study-5 and 10 year results. Br J Surg. 1982;69:693–696
  53. Bruce J. Operable cancer of the breast. Cancer. 1971;28(6):1443–1452
  54. Hamilton T, Langlands AO, Prescott RJ. The treatment of operable cancer of the breast: a clinical trial in the South-East region of Scotland. Br J Surg. 1974;61:758–761
  55. Fujimoto N, Amemiya A, Kondo M, Takeda A, Shigematsu N. Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection. Cancer. 2002;101:2155–2163
  56. Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable cancer of the breast. Br J Surg. 1980;67:170–174
  57. Zurrida S, Orecchia R, Galimberti V, et al. Axillary radiotherapy instead of axillary dissection: a randomised trial. Ann Surg Oncol. 2002;9(2):156–160
  58. Mansell RE, Fallowfield L, Kissin M, et al. Randomised multicentre trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98:599–609
  59. Kelley MC, Guilliano AE. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. In:  Bland KI,  Copeland EM editor. The breast: comprehensive management of benign and malignant disease. Philadelphia (USA): WB Saunders; 1998;p. 1100–1111
  60. Chetty U, Jack W, Prescott RJ, Tyler C, Roger A. Management of the axilla in operable breast cancer treated by breast conservation: a randomised trial. Br J Surg. 2000;87:163–169
  61. Alderman AK, McMahon L, Wilkins EG. The National utilisation of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plastic Reconstr Surg. 2003;111(2):695–703
  62. Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000;92(17):1422–1429
  63. Keith DJ, Walker MB, Walker LG, Heys SD, Sarkar TK, Hutcheon AW, et al. Women who wish breast reconstruction: characteristics, fears and hopes. Plastic Reconstr Surg. 2003;111(3):1051–1056
  64. Franzoi SL, Koehler V. Age and gender differences in body attitudes: a comparison of young and elderly adults. Int J Aging Hum Dev. 1998;47(1):1–10
  65. King MT, Kenny P, Shiell A, Hall J, Boyages J. Quality of life 3 months and 1 year after first treatment for early stage breast cancer: influence of treatment and patient characteristics. Qual Life Res. 2000;9:789–800
  66. Figueiredo MI, Cullen J, Hwang Y-T, Rowland JH, Mandelblatt JS. Breast cancer treatment in older women: does getting what you want improve your long term body image and mental health?. J Clin Oncol. 2004;22(19):4002–4009
  67. Lipa JE, Youssef AA, Kuerer HM, Robb GL, Chang DW. Breast reconstruction in older women: advantages of autogenous tissue. Plastic Reconstr Surg. 2005;111(3):1110–1121
  68. Girotto JA, Schreiber J, Nahabedian MY. Breast reconstruction in the elderly: preserving excellent quality of life. Ann Plastic Surg. 2003;50(6):572–578
  69. Reaby LL. Reasons why women who have mastectomy decide to have or not to have breast reconstruction. Plastic Reconstr Surg. 1998;101(7):1810–1818
  70. Handel N, Silverstein MJ, Waisman E, Waisman JR. Reasons why mastectomy patients do not have breast reconstruction. Plastic Reconstruct Surg. 1990;86(6):118–122
  71. Fallowfield LJ, Hall A, Maguire P, Baum M, A’Herne RP. Psycological effect of being offered choice of surgery for breast cancer. Br Med J. 1994;309:448;31
  72. Ernst MF, Voogd AC, Balder W, Klinkenbijl JHG, Roukema JA. Early and late morbidity associated with axillary levels I–III dissection in breast cancer. J Surg Oncol. 2002;79:151–155
  73. Kuehn T, Klauss W, Darsow M, et al. Long term morbidity following axillary dissection in breast cancer patients – clinical assessment, significance for life quality and the impact of demographic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275–286
  74. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Quality of life following breast conserving therapy or mastectomy: results of a 5 year prospective study. Breast J. 2003;10(3):223–231
  75. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95(3):279–293
  76. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580–584
  77. Petrek JA, Senie RT, Peters M, Rosen PP. Lympedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–1377
  78. Houterman S, Janssen-Heijnen MLG, Verheij CDGW, Louwman WJ, Vreugdenhil WJ, van der Sangen MJC, et al. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer. 2004;1–6
  79. Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery. Eur J Surg Oncol. 2003;29:711–717
  80. Burak WE, Goodman PS, Young DC, Farrar WB. Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. J Surg Oncol. 1998;64(1):27–31
  81. Salmon RJ, Cody HS, Vedrenne JB, Asselain B, Durand JC, Pilleron JP. Prevention of post operative lymphocoele after breast amputation. Presse Med. 1985;14(1):27–29
  82. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group. Ann Surg Oncol. 2006;13(4):491–500
  83. Swanson RS, Sawicka J, Wood WC. Treatment of carcinoma of the breast in the older geriatric patient. Surg Gynaecol Obstet. 1991;173:465–469
  84. Davis SJ, Karrer FW, Moor BJ, Rose SG, Eakins G. Characteristics of breast cancer in women over 80 years of age. Am J Surg. 1985;150:655–658
  85. Sorensen LT, Horby J, Friis E, Pilsgaard B, Jorgensen T. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol. 2002;28(8):815–820
  86. Ververs JMMA, Roumen RMH, Vingerhoets AJJM, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37:991–999
  87. Monypenny I. UK Symptomatic breast audit 1.4.2001–31.3.2002. British Association of Surgical Oncology; 2003.
  88. Kenny FS, Robertson JFR, Ellis IO, Elston CW, Blamey RW. Long term follow-up of elderly patients randomised to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. Breast. 1998;7:335–339
  89. Gazet J-C, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, et al. Prospective randomised trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol. 1994;20:207–214
  90. Fennessy M, Bates T, MacRae K, Riley D, Houghton J, Baum M. Late follow up of a randomised trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg. 2004;91(6):699–704
  91. Fentiman IS, Christiaens M-R, Paridaens R, et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer. 2003;39:309–316
  92. Mustacchi G, Ceccherini R, Milani S, et al. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomised controlled multicenter GRETA trial. Ann Oncol. 2003;14:414–420
  93. Willsher PC, Robertson JFR, Jackson L, Al-Hilaly M, Blamey RW. Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer. Breast. 1997;6:150–154
  94. Hind D, Wyld L, Reed MW, Beverley CB. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70+). In: The Cochrane Library, Issue 1. Chichester (UK): John Wiley & Sons, Ltd.; 2006;
  95. Mustacchi G, et al. Tamoxifen versus surgery plus tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials. In: Proceedings of ASCO; vol. 17 1998. p. 99a.
  96. Prescott RJ, Kunkler IH, Williams LJ, King CC, Jack W, van der Pol M, et al. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technology Assessment. 2007;11:31

PII: S0959-8049(07)00553-9

doi: 10.1016/j.ejca.2007.07.035

European Journal of Cancer
Volume 43, Issue 15 , Pages 2253-2263 , October 2007

Article Tools

* Image Usage & Resolution